Search for: "BIOTECH, INC." Results 181 - 200 of 1,249
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Nov 2017, 7:19 am by Heather Cobun
Osiris Therapeutics Inc. did not admit or deny any of the charges in the complaint, filed Thursday in U.S. [read post]
31 Oct 2017, 9:59 pm by Patent Docs
By Donald Zuhn -- Last year, two biotech companies announced that they had received institutional review board (IRB) approval for a study focused on the clinical intervention of brain death in humans. [read post]
25 Oct 2017, 11:23 am by David Jensen
Declining on behalf of the San Diego company was Jessica Yingling, president of Little Dog Communications Inc., of San Diego. [read post]
14 Sep 2017, 8:43 am by Daily Record Staff
RoosterBio Inc., a biotechnology tools company, on Thursday launched a new product portfolio that it says will improve manufacturing processes for adult stem cells. [read post]
12 Sep 2017, 5:22 pm by Lawrence B. Ebert
Litig. 1 (2007), Douglas Laycock wrote:in eBay Inc. v. [read post]
9 Aug 2017, 8:30 am by Daily Record Staff
Novavax Inc., a Gaithersburg biotech company, is pleased with its progress as it shows another quarterly loss. [read post]
31 Jul 2017, 3:30 am by Steve Brachmann
The Federal Circuit issued a decision in Regeneron Pharmaceuticals, Inc. v. [read post]
25 Jul 2017, 7:38 am by Daily Record Staff
Novavax Inc., a Gaithersburg-based biotechnology company, on Tuesday announced that it had seen positive data from its phase 2 trial of its respiratory syncytial virus F-protein nanoparticle vaccine candidate. [read post]
6 Jul 2017, 1:27 pm by Daily Record Staff
The European Patent Office told GlycoMimetics Inc., which is based in Rockville, that it plans to grant a patent related to its drug candidate GMI-1271. [read post]
22 May 2017, 5:03 am by Philip Segal
The earliest mention of Quiros in securities filings in the U.S. is in 2011, as an investor in a U.S. biotech company. [read post]
22 May 2017, 5:03 am by Philip Segal
The earliest mention of Quiros in securities filings in the U.S. is in 2011, as an investor in a U.S. biotech company. [read post]
15 May 2017, 9:50 pm by Patent Docs
Patent and Trademark Office has now filed its response brief in In re: Janssen Biotech, Inc., New York University, No. 2017-1257 (Fed. [read post]
6 Mar 2017, 10:01 am by David Jensen
Having said this, there are many reasons that drive stocks: the U.S. election, the pricing discussion… Many investors don’t discriminate, and just punish biotech as a whole. [read post]